174 related articles for article (PubMed ID: 21590716)
1. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines.
Fujimori J; Matsuo T; Shimose S; Kubo T; Ishikawa M; Yasunaga Y; Ochi M
J Orthop Res; 2011 Nov; 29(11):1707-11. PubMed ID: 21590716
[TBL] [Abstract][Full Text] [Related]
2. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
[TBL] [Abstract][Full Text] [Related]
3. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
5. Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos.
Izbicka E; Nishioka D; Marcell V; Raymond E; Davidson KK; Lawrence RA; Wheelhouse RT; Hurley LH; Wu RS; Von Hoff DD
Anticancer Drug Des; 1999 Aug; 14(4):355-65. PubMed ID: 10625928
[TBL] [Abstract][Full Text] [Related]
6. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
[TBL] [Abstract][Full Text] [Related]
7. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
Izbicka E; Wheelhouse RT; Raymond E; Davidson KK; Lawrence RA; Sun D; Windle BE; Hurley LH; Von Hoff DD
Cancer Res; 1999 Feb; 59(3):639-44. PubMed ID: 9973212
[TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells.
Binz N; Shalaby T; Rivera P; Shin-ya K; Grotzer MA
Eur J Cancer; 2005 Dec; 41(18):2873-81. PubMed ID: 16253503
[TBL] [Abstract][Full Text] [Related]
9. The different biological effects of TMPyP4 and cisplatin in the inflammatory microenvironment of osteosarcoma are attributed to G-quadruplex.
Chen J; Jin X; Mei Y; Shen Z; Zhu J; Shi H; Wang M; Zheng X; Liang G
Cell Prolif; 2021 Sep; 54(9):e13101. PubMed ID: 34296479
[TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma.
Shammas MA; Shmookler Reis RJ; Akiyama M; Koley H; Chauhan D; Hideshima T; Goyal RK; Hurley LH; Anderson KC; Munshi NC
Mol Cancer Ther; 2003 Sep; 2(9):825-33. PubMed ID: 14555701
[TBL] [Abstract][Full Text] [Related]
11. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
[TBL] [Abstract][Full Text] [Related]
12. Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines.
Zhou JM; Zhu XF; Lu YJ; Deng R; Huang ZS; Mei YP; Wang Y; Huang WL; Liu ZC; Gu LQ; Zeng YX
Oncogene; 2006 Jan; 25(4):503-11. PubMed ID: 16170347
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.
Mikami-Terao Y; Akiyama M; Yuza Y; Yanagisawa T; Yamada O; Kawano T; Agawa M; Ida H; Yamada H
Exp Eye Res; 2009 Aug; 89(2):200-8. PubMed ID: 19328784
[TBL] [Abstract][Full Text] [Related]
14. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of G-quadruplex-interactive agent TMPyP4 in K562 leukemic cells.
Mikami-Terao Y; Akiyama M; Yuza Y; Yanagisawa T; Yamada O; Yamada H
Cancer Lett; 2008 Mar; 261(2):226-34. PubMed ID: 18096315
[TBL] [Abstract][Full Text] [Related]
17. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
18. Arsenic induces telomerase expression and maintains telomere length in human cord blood cells.
Ferrario D; Collotta A; Carfi M; Bowe G; Vahter M; Hartung T; Gribaldo L
Toxicology; 2009 Jun; 260(1-3):132-41. PubMed ID: 19464579
[TBL] [Abstract][Full Text] [Related]
19. Expression of human telomerase reverse transcriptase splice variants is well correlated with low telomerase activity in osteosarcoma cell lines.
Fujiwara-Akita H; Maesawa C; Honda T; Kobayashi S; Masuda T
Int J Oncol; 2005 Apr; 26(4):1009-16. PubMed ID: 15753996
[TBL] [Abstract][Full Text] [Related]
20. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
